Transverse Medical
Ted Tarasow is the Director and Co-Founder of Transverse Medical. Prior to this, they were the Global Head of Digital Biology R&D at iCarbonX from April 2018 to March 2020. Ted has also held various other positions, including Senior Vice President of Research & Development at Tethys Bioscience, Inc. from June 2007 to May 2013, Director of the Biosecurity & Nanosciences Laboratory at Lawrence Livermore National Laboratory from January 2004 to December 2007, Vice President of Product Development at HealthTell Inc. from May 2013 to April 2018, and Founder, CSO & VP Chemistry at Invenux, Inc. from January 2000 to January 2003.
This person is not in the org chart
This person is not in any offices
Transverse Medical
Transverse Medical Inc. (TMI) is developing the POINT-GUARD™ Dynamic Cerebral Embolic Protection (CEP) medical device to address the devastating and costly problem of stroke during the large and growing number of heart valve procedures that occur annually around the world, such as Transcatheter Aortic Valve Replacement (TAVR).